Kaliciński P J, Ismail H, Jankowska I, Kamiński A, Pawłowska J, Drewniak T, Markiewicz M, Szymczak M
Department of Paediatric Surgery and Organ Transplantation, The Children's Memorial Health Institute, Warsaw, Poland.
Eur J Pediatr Surg. 2003 Oct;13(5):307-11. doi: 10.1055/s-2003-43570.
Progressive familial intrahepatic cholestasis (PFIC, Byler's disease) is an autosomal recessive disorder resulting in liver fibrosis/cirrhosis and liver insufficiency. Before the 1990s, liver transplantation was the only effective therapy for these children. During the last 12 years, two alternative methods of surgical treatment have been proposed: partial external biliary diversion (PEBD) and ileal bypass procedure (IB), which allow for effective elimination of bile acids accumulated in the body. In this study, we compare the efficacy of these surgical techniques for PFIC.
During the last 20 years, we have treated 52 children with PFIC. PEBD was done in 21 patients (since 1995), and IB in 5 patients (since 1998), transplantation was performed in 9 patients (since 1990). The efficacy of non-transplantation surgical treatment was assessed by patients' clinical outcome, liver biochemistry, and survival without transplantation during a follow-up period of 12 to 48 months.
In 15 out of 21 patients clinical symptoms improved after PEBD and liver function tests normalised (blood bile acids), 1 patient had to be converted to IB due to too high output biliary fistula, 2 patients were transplanted and 3 are considered for transplantation. Out of the 5 children after IB, 4 improved clinically and biochemically, but, after 12 months, symptoms recurred in 3 patients, one patient was converted successfully to PEBD. No significant influence on growth was observed, irrespective of the type of treatment in this group of patients.
PEBD is more effective than IB for the permanent improvement of symptoms of PFIC. Ileal bypass procedure, although initially effective, does not ensure good long-term results in more than 50 % of patients, probably due to intestinal re-absorption of bile acids increasing over time.
进行性家族性肝内胆汁淤积症(PFIC,比勒氏病)是一种常染色体隐性疾病,可导致肝纤维化/肝硬化及肝功能不全。20世纪90年代以前,肝移植是治疗这些患儿的唯一有效疗法。在过去12年里,提出了两种替代性手术治疗方法:部分外引流术(PEBD)和回肠旁路术(IB),这两种方法能有效清除体内蓄积的胆汁酸。在本研究中,我们比较了这些手术技术治疗PFIC的疗效。
在过去20年里,我们共治疗了52例PFIC患儿。21例患者接受了PEBD(自1995年起),5例接受了IB(自1998年起),9例接受了移植手术(自1990年起)。通过患者的临床结局、肝脏生化指标以及在12至48个月随访期内未进行移植的生存率,评估非移植手术治疗的疗效。
21例接受PEBD的患者中,15例临床症状改善,肝功能检查(血胆汁酸)恢复正常,1例因胆汁瘘流量过大而转为IB,另外2例接受了移植手术,3例考虑进行移植。5例接受IB的患儿中,4例临床和生化指标改善,但12个月后,3例症状复发,1例成功转为PEBD。在这组患者中,无论采用何种治疗方式,均未观察到对生长有显著影响。
对于永久性改善PFIC症状,PEBD比IB更有效。回肠旁路术虽然最初有效,但超过50%的患者无法保证良好的长期效果,这可能是由于随着时间推移胆汁酸的肠道重吸收增加所致。